• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个与临床特征相关的四基因标志物可以更好地预测前列腺癌的预后。

A four-gene signature associated with clinical features can better predict prognosis in prostate cancer.

机构信息

Department of Urology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Cancer Med. 2020 Nov;9(21):8202-8215. doi: 10.1002/cam4.3453. Epub 2020 Sep 13.

DOI:10.1002/cam4.3453
PMID:32924329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7643642/
Abstract

Prostate cancer (PCa) is one of the most deadly urinary tumors in men globally, and the 5-year over survival is poor due to metastasis of tumor. It is significant to explore potential biomarkers for early diagnosis and personalized therapy of PCa. In the present study, we performed an integrated analysis based on multiple microarrays in the Gene Expression Omnibus (GEO) dataset and obtained differentially expressed genes (DEGs) between 510 PCa and 259 benign issues. The weighted correlation network analysis indicated that prognostic profile was the most relevant to DEGs. Then, univariate and multivariate COX regression analyses were conducted and four prognostic genes were obtained to establish a four-gene prognostic model. And the predictive effect and expression profiles of the four genes were well validated in another GEO dataset, The Cancer Genome Atlas and the Human Protein Atlas datasets. Furthermore, combination of four-gene model and clinical features was analyzed systematically to guide the prognosis of patients with PCa to a largest extent. In summary, our findings indicate that four genes had important prognostic significance in PCa and combination of four-gene model and clinical features could achieve a better prediction to guide the prognosis of patients with PCa.

摘要

前列腺癌(PCa)是全球男性中最致命的泌尿系统肿瘤之一,由于肿瘤转移,5 年生存率较差。探索前列腺癌早期诊断和个体化治疗的潜在生物标志物具有重要意义。本研究基于 GEO 数据集的多个微阵列进行了综合分析,获得了 510 例前列腺癌和 259 例良性病例之间的差异表达基因(DEGs)。加权相关网络分析表明,预后特征与 DEGs 最相关。然后进行单变量和多变量 COX 回归分析,得到 4 个预后基因,建立 4 基因预后模型。该模型在另一个 GEO 数据集、癌症基因组图谱和人类蛋白质图谱数据集中得到了很好的验证。此外,还系统地分析了四基因模型与临床特征的结合,以最大限度地指导前列腺癌患者的预后。总之,我们的研究结果表明,这四个基因在前列腺癌中有重要的预后意义,四基因模型与临床特征的结合可以更好地预测前列腺癌患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ae/7643642/57109c9bd23b/CAM4-9-8202-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ae/7643642/c6ba1c9bfcd0/CAM4-9-8202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ae/7643642/57e015a0b1b3/CAM4-9-8202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ae/7643642/dcc8329757f0/CAM4-9-8202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ae/7643642/57109c9bd23b/CAM4-9-8202-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ae/7643642/c6ba1c9bfcd0/CAM4-9-8202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ae/7643642/57e015a0b1b3/CAM4-9-8202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ae/7643642/dcc8329757f0/CAM4-9-8202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33ae/7643642/57109c9bd23b/CAM4-9-8202-g004.jpg

相似文献

1
A four-gene signature associated with clinical features can better predict prognosis in prostate cancer.一个与临床特征相关的四基因标志物可以更好地预测前列腺癌的预后。
Cancer Med. 2020 Nov;9(21):8202-8215. doi: 10.1002/cam4.3453. Epub 2020 Sep 13.
2
Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.基因特征可预测根治性治疗后原发性前列腺癌患者的生化无复发生存。
Cancer Med. 2021 Sep;10(18):6492-6502. doi: 10.1002/cam4.4092. Epub 2021 Aug 28.
3
Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.探索肿瘤突变负担作为前列腺癌的预后生物标志物及相关枢纽基因鉴定。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211052154. doi: 10.1177/15330338211052154.
4
Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.使用三代谢基因风险评分模型预测前列腺癌患者的生化无复发生存。
BMC Cancer. 2022 Mar 4;22(1):239. doi: 10.1186/s12885-022-09331-8.
5
Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.基于整合生物信息学分析鉴定与结直肠癌患者诊断和预后相关的生物标志物。
Gene. 2019 Apr 15;692:119-125. doi: 10.1016/j.gene.2019.01.001. Epub 2019 Jan 14.
6
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.TMEFF2 调控的细胞周期相关基因特征可预测前列腺癌的复发风险。
BMC Cancer. 2019 May 6;19(1):423. doi: 10.1186/s12885-019-5592-6.
7
Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.DNA 激活的蛋白激酶催化多肽的下调可减弱肿瘤进展,并且是前列腺癌生存的独立预后预测指标。
Urol Oncol. 2017 Mar;35(3):111.e15-111.e23. doi: 10.1016/j.urolonc.2016.10.012. Epub 2016 Nov 14.
8
High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.ASPM的高表达与前列腺癌患者的肿瘤进展相关,并预示着不良预后。
Int Urol Nephrol. 2017 May;49(5):817-823. doi: 10.1007/s11255-017-1545-7. Epub 2017 Feb 17.
9
Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.Rce1过表达与前列腺癌的肿瘤进展呈正相关,并预示着不良预后。
Hum Pathol. 2016 Jan;47(1):109-14. doi: 10.1016/j.humpath.2015.08.021. Epub 2015 Sep 28.
10
A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.一种潜在的由四种长链非编码RNA组成的标志物可预测前列腺癌的无生化复发生存率和无病生存率。
Int Urol Nephrol. 2017 May;49(5):825-835. doi: 10.1007/s11255-017-1536-8. Epub 2017 Feb 10.

引用本文的文献

1
Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients.前列腺癌患者预后基因特征的系统评价与综合分析
Discov Oncol. 2023 Dec 19;14(1):234. doi: 10.1007/s12672-023-00847-4.
2
Therapeutic implications for localized prostate cancer by multiomics analyses of the ageing microenvironment landscape.基于衰老微环境全景的多组学分析对局限性前列腺癌的治疗意义。
Int J Biol Sci. 2023 Jul 31;19(12):3951-3969. doi: 10.7150/ijbs.85209. eCollection 2023.
3
The Development of a Gleason Score-Related Gene Signature for Predicting the Prognosis of Prostate Cancer.

本文引用的文献

1
A Three-Gene Classifier Associated With MicroRNA-Mediated Regulation Predicts Prostate Cancer Recurrence After Radical Prostatectomy.一种与微小RNA介导的调控相关的三基因分类器可预测前列腺癌根治术后的复发情况。
Front Genet. 2020 Feb 4;10:1402. doi: 10.3389/fgene.2019.01402. eCollection 2019.
2
Genetic association analysis identifies a role for ANO5 in prostate cancer progression.基因关联分析确定了ANO5在前列腺癌进展中的作用。
Cancer Med. 2020 Apr;9(7):2372-2378. doi: 10.1002/cam4.2909. Epub 2020 Feb 6.
3
Global incidence of prostate cancer in developing and developed countries with changing age structures.
用于预测前列腺癌预后的Gleason评分相关基因特征的开发
J Clin Med. 2022 Dec 1;11(23):7164. doi: 10.3390/jcm11237164.
4
A novel 8-gene panel for prediction of early biochemical recurrence in patients with prostate cancer after radical prostatectomy.一种用于预测前列腺癌患者根治性前列腺切除术后早期生化复发的新型8基因检测板。
Am J Cancer Res. 2022 Jul 15;12(7):3318-3332. eCollection 2022.
5
Characterization of a Pyroptosis-Related Signature for Prognosis Prediction and Immune Microenvironment Infiltration in Prostate Cancer.中文译文:前列腺癌中焦亡相关特征signature 用于预后预测和免疫微环境浸润的研究
Comput Math Methods Med. 2022 Apr 27;2022:8233840. doi: 10.1155/2022/8233840. eCollection 2022.
6
Identification and Validation of a Prognostic Signature for Prostate Cancer Based on Ferroptosis-Related Genes.基于铁死亡相关基因的前列腺癌预后标志物的鉴定与验证
Front Oncol. 2021 Jul 15;11:623313. doi: 10.3389/fonc.2021.623313. eCollection 2021.
7
A zinc finger protein gene signature enables bladder cancer treatment stratification.锌指蛋白基因特征可实现膀胱癌治疗分层。
Aging (Albany NY). 2021 May 7;13(9):13023-13038. doi: 10.18632/aging.202984.
发展中国家和发达国家中前列腺癌的全球发病率与不断变化的年龄结构。
PLoS One. 2019 Oct 24;14(10):e0221775. doi: 10.1371/journal.pone.0221775. eCollection 2019.
4
Identification of prognosis biomarkers of prostatic cancer in a cohort of 498 patients from TCGA.在 TCGA 的 498 例患者队列中鉴定前列腺癌的预后生物标志物。
Curr Probl Cancer. 2019 Dec;43(6):100503. doi: 10.1016/j.currproblcancer.2019.100503. Epub 2019 Sep 20.
5
A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.一种基于9个长链非编码RNA特征的列线图,用于改善透明细胞肾细胞癌的预后预测。
Cancer Cell Int. 2019 Aug 5;19:208. doi: 10.1186/s12935-019-0928-5. eCollection 2019.
6
Genome-wide identification of the essential protein-coding genes and long non-coding RNAs for human pan-cancer.全基因组鉴定人类泛癌必需的蛋白质编码基因和长非编码 RNA
Bioinformatics. 2019 Nov 1;35(21):4344-4349. doi: 10.1093/bioinformatics/btz230.
7
Emerging therapeutic targets for patients with advanced prostate cancer.晚期前列腺癌患者的新兴治疗靶点。
Cancer Treat Rev. 2019 Jun;76:1-9. doi: 10.1016/j.ctrv.2019.03.002. Epub 2019 Mar 19.
8
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.根治性治疗后生化复发对前列腺癌预后的价值:系统评价。
Eur Urol. 2019 Jun;75(6):967-987. doi: 10.1016/j.eururo.2018.10.011. Epub 2018 Oct 17.
9
Role of Extracellular Matrix in Development and Cancer Progression.细胞外基质在发育和癌症进展中的作用。
Int J Mol Sci. 2018 Oct 4;19(10):3028. doi: 10.3390/ijms19103028.
10
A four-gene-based prognostic model predicts overall survival in patients with hepatocellular carcinoma.基于四个基因的预后模型可预测肝细胞癌患者的总生存期。
J Cell Mol Med. 2018 Dec;22(12):5928-5938. doi: 10.1111/jcmm.13863. Epub 2018 Sep 24.